companydata.dkcompanydata.dk

ZP SPV 3 K/S: Financial statements 2023

CVR: 41038039

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

ZP SPV 3 K/S (CVR 41038039) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 7,448,000 and a net result of DKK 1,061,000 compared with DKK -1,791,000 the year before. That is a decrease of 80.3% compared with the year before. The profit margin was 14.2%. Equity in the 2023 report amounted to DKK 36,235,000. The solvency ratio was 79.9%.

Revenue
DKK 7,448,000
Gross Profit
DKK 7,448,000
Profit/Loss
DKK 1,061,000
Equity
DKK 36,235,000
Total Assets
DKK 45,374,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20237.4M7.4M1.1M36.2M-
202237.8M37.8M-1.8M35.2M-
20211.6M USD1.6M USD50K USD5.6M USD-
20201K USD1K USD-118 USD6K USD-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

ZP SPV 3 K/S: The 2022 annual report is outJun 15, 2023

ZP SPV 3 K/S has published its annual report for 2022. Revenue came to DKK 37,755,000, and the net result was DKK -1,791,000.

About ZP SPV 3 K/S

ZP SPV 3 K/S is a Danish company of the type Kommanditselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of ZP General Partner 3 ApS. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,039,000 compared with DKK -34,739,000 the year before. Equity in the 2025 report amounted to DKK 429,000.

Source: annual report 2025, Danish Business Authority

Other financial years